- Home
- COCH vs EVAX Comparison
COCH vs EVAX Comparison
Compare COCH & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- EVAX
- Stock Information
- Founded
- COCH 1995
- EVAX 2008
- Country
- COCH United States
- EVAX Denmark
- Employees
- COCH N/A
- EVAX N/A
- Industry
- COCH Blank Checks
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COCH Finance
- EVAX Health Care
- Exchange
- COCH Nasdaq
- EVAX Nasdaq
- Market Cap
- COCH 20.9M
- EVAX 17.8M
- IPO Year
- COCH N/A
- EVAX 2021
- Fundamental
- Price
- COCH $0.71
- EVAX $6.34
- Analyst Decision
- COCH Strong Buy
- EVAX Strong Buy
- Analyst Count
- COCH 1
- EVAX 3
- Target Price
- COCH $9.50
- EVAX $12.33
- AVG Volume (30 Days)
- COCH 552.0K
- EVAX 551.8K
- Earning Date
- COCH 10-31-2025
- EVAX 11-06-2025
- Dividend Yield
- COCH N/A
- EVAX N/A
- EPS Growth
- COCH N/A
- EVAX N/A
- EPS
- COCH N/A
- EVAX N/A
- Revenue
- COCH $222,000.00
- EVAX $7,650,000.00
- Revenue This Year
- COCH $3.66
- EVAX $129.34
- Revenue Next Year
- COCH $31.19
- EVAX N/A
- P/E Ratio
- COCH N/A
- EVAX N/A
- Revenue Growth
- COCH N/A
- EVAX 132.17
- 52 Week Low
- COCH $0.70
- EVAX $1.20
- 52 Week High
- COCH $2.32
- EVAX $13.40
- Technical
- Relative Strength Index (RSI)
- COCH 38.19
- EVAX 53.92
- Support Level
- COCH $0.70
- EVAX $5.51
- Resistance Level
- COCH $0.76
- EVAX $6.01
- Average True Range (ATR)
- COCH 0.06
- EVAX 0.67
- MACD
- COCH 0.00
- EVAX -0.14
- Stochastic Oscillator
- COCH 8.60
- EVAX 55.91
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.